{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:19:31Z","timestamp":1789697971221,"version":"4.0.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:00:00Z","timestamp":1693699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-GM129325"],"award-info":[{"award-number":["R01-GM129325"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU18\/04615"],"award-info":[{"award-number":["FPU18\/04615"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2019FI_B00352"],"award-info":[{"award-number":["2019FI_B00352"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR2021 00092"],"award-info":[{"award-number":["SGR2021 00092"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["SGR2021 01140"],"award-info":[{"award-number":["SGR2021 01140"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003741","name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["P21\/00150"],"award-info":[{"award-number":["P21\/00150"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00400"],"award-info":[{"award-number":["PI20\/00400"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["CP19\/00028"],"award-info":[{"award-number":["CP19\/00028"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.actbio.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:57:33Z","timestamp":1694001453000},"page":"543-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["High-precision targeting and destruction of cancer-associated PDGFR-\u03b2+ stromal fibroblasts through self-assembling, protein-only nanoparticles"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-8274","authenticated-orcid":false,"given":"Eric","family":"Volt\u00e0-Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Alba-Castell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naroa","family":"Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isolda","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5249-8304","authenticated-orcid":false,"given":"H\u00e8ctor","family":"L\u00f3pez-Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8789-1883","authenticated-orcid":false,"given":"Alejandro","family":"S\u00e1nchez-Chardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2615-4521","authenticated-orcid":false,"given":"Antonio","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugutz","family":"Unzueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-0424","authenticated-orcid":false,"given":"Esther","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Mangues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2023.09.001_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2023.09.001_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd2155","article-title":"Why is cancer drug discovery so difficult?","volume":"6","author":"Kamb","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2023.09.001_bib0003","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.trecan.2020.04.002","article-title":"Targeting glycosylation: a new road for cancer drug discovery","volume":"6","author":"Costa","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.actbio.2023.09.001_bib0004","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0005","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/35101008","article-title":"Cancer gene therapy: fringe or cutting edge?","volume":"1","author":"McCormick","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2023.09.001_bib0006","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrd2137","article-title":"Tumour-initiating cells: challenges and opportunities for anticancer drug discovery","volume":"8","author":"Zhou","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2023.09.001_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2018.12.004","article-title":"Protein-driven nanomedicines in oncotherapy","volume":"47","author":"Casanova","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2023.09.001_bib0009","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.11.002","article-title":"Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy","volume":"69","author":"Raj","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0010","first-page":"198","article-title":"Nanoparticle-delivered chemotherapy: old drugs in new packages","volume":"31","author":"Lee","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.actbio.2023.09.001_bib0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.addr.2017.05.006","article-title":"Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment","volume":"119","author":"David","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2023.09.001_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2023.09.001_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.actbio.2023.09.001_bib0014","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/13543776.2017.1344216","article-title":"Targeted nanotechnologies for cancer intervention: a patent review (2010-2016)","volume":"27","author":"Pradeep","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.actbio.2023.09.001_bib0015","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/cancers13122929","article-title":"Biparatopic protein nanoparticles for the precision therapy of CXCR4+ cancers","volume":"13","author":"Cano-Garrido","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2023.09.001_bib0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd4519","article-title":"Principles in the design of ligand-targeted cancer therapeutics and imaging agents","volume":"14","author":"Srinivasarao","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2023.09.001_bib0017","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/acs.bioconjchem.8b00804","article-title":"Multivalency in drug delivery\u2013when is it too much of a good thing?","volume":"30","author":"Tjandra","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2023.09.001_bib0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.matlet.2015.04.055","article-title":"Formulating tumor-homing peptides as regular nanoparticles enhances receptor-mediated cell penetrability","volume":"154","author":"Xu","year":"2015","journal-title":"Mater. Lett."},{"key":"10.1016\/j.actbio.2023.09.001_bib0019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/pharmaceutics15020525","article-title":"Multimeric RGD-based strategies for selective drug delivery to tumor tissues","volume":"15","author":"Cossu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2023.09.001_bib0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ml300312b","article-title":"Multivalent interactions: synthesis and evaluation of melanotropin multimers\u2013tools for melanoma targeting","volume":"4","author":"Brabez","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.actbio.2023.09.001_bib0021","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2023.09.001_bib0022","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.actbio.2023.09.001_bib0023","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0024","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","article-title":"Toxicology and clinical potential of nanoparticles","volume":"6","author":"Yildirimer","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.actbio.2023.09.001_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/smll.200700595","article-title":"Cytotoxicity of Nanoparticles","volume":"4","author":"Lewinski","year":"2008","journal-title":"Small"},{"key":"10.1016\/j.actbio.2023.09.001_bib0026","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1021\/nn4055732","article-title":"In vivo architectonic stability of fully de novo designed protein-only nanoparticles","volume":"8","author":"Cespedes","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2023.09.001_bib0027","doi-asserted-by":"crossref","first-page":"e8772","DOI":"10.15252\/emmm.201708772","article-title":"Selective depletion of metastatic stem cells as therapy for human colorectal cancer","volume":"10","author":"C\u00e9spedes","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.actbio.2023.09.001_bib0028","first-page":"4533","article-title":"Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles","volume":"7","author":"Unzueta","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2023.09.001_bib0029","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3324\/haematol.2018.211490","article-title":"A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models","volume":"105","author":"Falg\u00e0s","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.actbio.2023.09.001_bib0030","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/biomedicines10071680","article-title":"Novel endometrial cancer models using sensitive metastasis tracing for CXCR4-targeted therapy in advanced disease","volume":"10","author":"Medina-Guti\u00e9rrez","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.actbio.2023.09.001_bib0031","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tibtech.2017.11.007","article-title":"Protein-based therapeutic killing for cancer therapies","volume":"36","author":"Serna","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700167","article-title":"Cancer associated fibroblasts: the architects of stroma remodeling","volume":"18","author":"Santi","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.actbio.2023.09.001_bib0033","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2023.09.001_bib0034","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2023.09.001_bib0035","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.18632\/aging.202952","article-title":"PDGFR-beta(+) fibroblasts deteriorate survival in human solid tumors: a meta-analysis","volume":"13","author":"Hu","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.actbio.2023.09.001_bib0036","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.3390\/cancers13184720","article-title":"The role of cancer-associated fibroblasts in cancer invasion and metastasis","volume":"13","author":"Asif","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2023.09.001_bib0037","first-page":"2178","article-title":"Platelet\u2011derived growth factor receptor\u2011\u03b2 gene expression relates to recurrence in colorectal cancer","volume":"39","author":"Fujino","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.actbio.2023.09.001_bib0038","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1593\/neo.121726","article-title":"PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells","volume":"15","author":"Steller","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.actbio.2023.09.001_bib0039","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.critrevonc.2018.08.002","article-title":"The role of PDGF-B\/PDGFR-BETA axis in the normal development and carcinogenesis of the breast","volume":"131","author":"Jitariu","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0040","doi-asserted-by":"crossref","first-page":"97851","DOI":"10.18632\/oncotarget.18415","article-title":"Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients","volume":"8","author":"Avril","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.actbio.2023.09.001_bib0041","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbrc.2018.08.181","article-title":"Platelet-derived growth factor receptor alpha (PDGFR\u03b1) is overexpressed in NK\/T-cell lymphoma and mediates cell survival","volume":"504","author":"Lu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2023.09.001_bib0042","doi-asserted-by":"crossref","first-page":"43378","DOI":"10.1038\/srep43378","article-title":"High expression of PDGFR-\u03b2 in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence","volume":"7","author":"Nordby","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2023.09.001_bib0043","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5603\/GP.a2019.0045","article-title":"The expression of Platelet-derived Growth factor receptors (PDGFRs) and their correlation with overall survival of patients with ovarian cancer","volume":"90","author":"Szubert","year":"2019","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.addr.2017.09.022","article-title":"PDGF receptors in tumor stroma: biological effects and associations with prognosis and response to treatment","volume":"121","author":"\u00d6stman","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2023.09.001_bib0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","article-title":"Targeting the tumour stroma to improve cancer therapy","volume":"15","author":"Valkenburg","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0046","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/molecules26010041","article-title":"Development of radiogallium-labeled peptides for platelet-derived growth factor receptor \u03b2 (PDGFR\u03b2) imaging: influence of different linkers","volume":"26","author":"Effendi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.actbio.2023.09.001_bib0047","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.toxlet.2018.05.033","article-title":"Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism","volume":"295","author":"Yang","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.actbio.2023.09.001_bib0048","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2017.11.007","article-title":"The PDGF\/PDGFR pathway as a drug target","volume":"62","author":"Papadopoulos","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.actbio.2023.09.001_bib0049","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2022.01.017","article-title":"Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery","volume":"343","author":"Serna","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2023.09.001_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107817","article-title":"Insights on the emerging biotechnology of histidine-rich peptides","volume":"54","author":"Lopez-Laguna","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.actbio.2023.09.001_bib0051","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3390\/ijms23094958","article-title":"An in silico methodology that facilitates decision making in the engineering of nanoscale protein Materials","volume":"23","author":"Parlad\u00e9","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2023.09.001_bib0052","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1038\/s41467-021-23966-4","article-title":"Designed and biologically active protein lattices","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2023.09.001_bib0053","doi-asserted-by":"crossref","first-page":"107817","DOI":"10.1016\/j.biotechadv.2021.107817","article-title":"Insights on the emerging biotechnology of histidine-rich peptides","volume":"54","author":"L\u00f3pez-Laguna","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.actbio.2023.09.001_bib0054","doi-asserted-by":"crossref","first-page":"12341","DOI":"10.1021\/acssuschemeng.1c04256","article-title":"Biofabrication of functional protein nanoparticles through simple His-tag engineering","volume":"9","author":"Lopez-Laguna","year":"2021","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.actbio.2023.09.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/adsu.202000167","article-title":"Strategies for fabricating protein films for biomaterial applications","volume":"5","author":"Gopalakrishnan","year":"2021","journal-title":"Adv. Sustain. Syst."},{"key":"10.1016\/j.actbio.2023.09.001_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107753","article-title":"Building protein networks in synthetic systems from the bottom-up","volume":"49","author":"Shim","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.actbio.2023.09.001_bib0057","doi-asserted-by":"crossref","first-page":"e1578","DOI":"10.1002\/wnan.1578","article-title":"Highly ordered protein cage assemblies: a toolkit for new materials","volume":"12","author":"Korpi","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0058","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ijch.201900051","article-title":"Order\/disorder in protein and peptide-based biomaterials","volume":"60","author":"Ulijn","year":"2020","journal-title":"Isr. J. Chem."},{"key":"10.1016\/j.actbio.2023.09.001_bib0059","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sbi.2020.05.001","article-title":"Recent progress in designing protein-based supramolecular assemblies","volume":"63","author":"Hansen","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0060","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1039\/D0TB00139B","article-title":"Natural protein bioinspired materials for regeneration of hard tissues","volume":"8","author":"Xu","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2023.09.001_bib0061","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1541-7786.MCR-12-0071","article-title":"Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer","volume":"10","author":"Najy","year":"2012","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.actbio.2023.09.001_bib0062","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11307-012-0578-7","article-title":"Peptide-based targeting of the platelet-derived growth factor receptor beta","volume":"15","author":"Askoxylakis","year":"2013","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0063","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2967\/jnumed.113.121814","article-title":"Imaging of platelet-derived growth factor receptor beta expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591","volume":"55","author":"Tolmachev","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.actbio.2023.09.001_bib0064","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1021\/mp500284t","article-title":"Gallium-68-labeled affibody molecule for PET imaging of PDGFR\u03b2 expression in vivo","volume":"11","author":"Strand","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2023.09.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202001885","article-title":"Engineering protein nanoparticles out from components of the human microbiome","volume":"16","author":"L\u00f3pez-Laguna","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.actbio.2023.09.001_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-10-1","article-title":"Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulfide bond containing proteins expressed in the cytoplasm of E.coli","volume":"10","author":"Nguyen","year":"2011","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.actbio.2023.09.001_bib0067","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pep.2011.03.005","article-title":"Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase","volume":"79","author":"Veggiani","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.actbio.2023.09.001_bib0068","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nmeth0709-477","article-title":"Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates","volume":"6","author":"Magnusdottir","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.actbio.2023.09.001_bib0069","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40843-019-9582-9","article-title":"Controlling self-assembling and tumor cell-targeting of protein-only nanoparticles through modular protein engineering","volume":"63","author":"Volt\u00e0-Dur\u00e1n","year":"2019","journal-title":"Sic. China Mater."},{"key":"10.1016\/j.actbio.2023.09.001_bib0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2023.09.001_bib0071","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.actbio.2023.09.001_bib0072","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1038\/onc.2012.342","article-title":"Snail1 controls TGF-\u03b2 responsiveness and differentiation of mesenchymal stem cells","volume":"32","author":"Batlle","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2023.09.001_bib0073","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1158\/0008-5472.CAN-16-0176","article-title":"Snail1-dependent activation of cancer-associated fibroblast controls epithelial tumor cell invasion and metastasis","volume":"76","author":"Alba-Castell\u00f3n","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2023.09.001_bib0074","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1158\/0008-5472.CAN-04-4510","article-title":"Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene","volume":"65","author":"Grum-Schwensen","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2023.09.001_bib0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/bjc.1993.453","article-title":"Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts","volume":"68","author":"Noel","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.actbio.2023.09.001_bib0076","article-title":"A mouse model to investigate the role of cancer-associated fibroblasts in tumor growth","volume":"166","author":"Jelinek","year":"2020","journal-title":"J. Vis. Exp. JoVE"},{"key":"10.1016\/j.actbio.2023.09.001_bib0077","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/ijc.28613","article-title":"Protumorigenic effects of Snail-expression fibroblasts on colon cancer cells","volume":"134","author":"Herrera","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.actbio.2023.09.001_bib0078","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.tibs.2020.08.003","article-title":"Divalent cations: a molecular glue for protein materials","volume":"45","author":"L\u00f3pez-Laguna","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.actbio.2023.09.001_bib0079","doi-asserted-by":"crossref","first-page":"8714","DOI":"10.1016\/j.biomaterials.2012.08.033","article-title":"Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles","volume":"33","author":"Unzueta","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2023.09.001_bib0080","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s40843-021-1914-0","article-title":"The spectrum of building block conformers sustains the biophysical properties of clinically-oriented self-assembling protein nanoparticles","volume":"65","author":"Volt\u00e0-Dur\u00e1n","year":"2022","journal-title":"Sci. China Mater."},{"key":"10.1016\/j.actbio.2023.09.001_bib0081","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1002\/adma.201503676","article-title":"Bottom-up instructive quality control in the biofabrication of smart protein materials","volume":"27","author":"Rueda","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2023.09.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1002\/ppsc.201900304","article-title":"Nanostructure empowers active tumor targeting in ligand-based molecular delivery","volume":"36","author":"L\u00f3pez-Laguna","year":"2019","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.actbio.2023.09.001_bib0083","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/pharmaceutics15030727","article-title":"T22-PE24-H6 nanotoxin selectively kills CXCR4-high expressing AML patient cells in vitro and potently blocks dissemination in vivo","volume":"15","author":"N\u00fa\u00f1ez","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2023.09.001_bib0084","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1039\/D2BM02026B","article-title":"A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy","volume":"11","author":"Zhao","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2023.09.001_bib0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00280-019-03875-6","article-title":"Moxetumomab pasudotox-tdfk for relapsed\/refractory hairy cell leukemia: a review of clinical considerations","volume":"84","author":"Nobre","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0086","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/adma.200801393","article-title":"Size-dependent endocytosis of nanoparticles","volume":"21","author":"Zhang","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2023.09.001_bib0087","doi-asserted-by":"crossref","DOI":"10.1063\/1.3293303","article-title":"Effects of particle size and ligand density on the kinetics of receptor-mediated endocytosis of nanoparticles","volume":"96","author":"Yuan","year":"2010","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.actbio.2023.09.001_bib0088","unstructured":"Banerjee A., Berzhkovskii A., Nossal R. Efficiency of cellular uptake of nanoparticles via receptor-mediated endocytosis. arXiv preprint arXiv:14117348 2014."},{"key":"10.1016\/j.actbio.2023.09.001_bib0089","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2023.09.001_bib0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tibtech.2015.02.007","article-title":"Towards protein-based viral mimetics for cancer therapies","volume":"33","author":"Unzueta","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0091","doi-asserted-by":"crossref","DOI":"10.1039\/C8NR09431D","article-title":"Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity","author":"Stefanick","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2023.09.001_bib0092","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/acs.biomac.9b00016","article-title":"Ligand-binding cooperativity effects in polymer-protein conjugation","volume":"20","author":"Reichenwallner","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2023.09.001_bib0093","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1021\/acs.chemrev.8b00195","article-title":"Cooperativity principles in self-assembled nanomedicine","volume":"118","author":"Li","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actbio.2023.09.001_bib0094","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.2147\/IJN.S168053","article-title":"Recent advances in \"smart\" delivery systems for extended drug release in cancer therapy","volume":"13","author":"Kalaydina","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2023.09.001_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.11.014","article-title":"Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours","volume":"317","author":"Debie","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2023.09.001_bib0096","article-title":"Protein based nanostructures for drug delivery","volume":"2018","author":"Verma","year":"2018","journal-title":"J. Pharm."},{"key":"10.1016\/j.actbio.2023.09.001_bib0097","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-3155-12-5","article-title":"Engineered nanoparticles interacting with cells: size matters","volume":"12","author":"Shang","year":"2014","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0098","first-page":"49","article-title":"CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma","volume":"41","author":"Rioja-Blanco","year":"2022","journal-title":"J. Exp. Clin. Cancer res. CR"},{"key":"10.1016\/j.actbio.2023.09.001_bib0099","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2147\/IJN.S289733","article-title":"Specific cytotoxic effect of an auristatin nanoconjugate towards CXCR4(+) diffuse large B-cell lymphoma Cells","volume":"16","author":"Falg\u00e0s","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2023.09.001_bib0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.actbio.2020.11.018","article-title":"Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles","volume":"119","author":"Volta-Duran","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2023.09.001_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121258","article-title":"A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model","volume":"280","author":"Pallar\u00e8s","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2023.09.001_bib0102","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev-pharmtox-032320-110338","article-title":"Nanoparticle toxicology","volume":"61","author":"Yang","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12989-019-0299-z","article-title":"Cellular toxicity and immunological effects of carbon-based nanomaterials","volume":"16","author":"Yuan","year":"2019","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nantod.2019.03.010","article-title":"Nanoparticle translocation and multi-organ toxicity: a particularly small problem","volume":"26","author":"Raftis","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.actbio.2023.09.001_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yrtph.2018.08.003","article-title":"A review on silver nanoparticles-induced ecotoxicity and the underlying toxicity mechanisms","volume":"98","author":"Du","year":"2018","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.actbio.2023.09.001_bib0106","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/jbm.a.35384","article-title":"Effects of physicochemical properties of nanomaterials on their toxicity","volume":"103","author":"Li","year":"2015","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"10.1016\/j.actbio.2023.09.001_bib0107","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev-pharmtox-010611-134615","article-title":"Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery","volume":"54","author":"Palombo","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.actbio.2023.09.001_bib0108","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00216-010-3996-x","article-title":"Toxicity assessment of nanomaterials: methods and challenges","volume":"398","author":"Dhawan","year":"2010","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123005263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123005263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:09:49Z","timestamp":1761674989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706123005263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":108,"alternative-id":["S1742706123005263"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2023.09.001","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-precision targeting and destruction of cancer-associated PDGFR-\u03b2+ stromal fibroblasts through self-assembling, protein-only nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}